stomach cancer
MiRxes Gets $50M in Series D Funding, Applies to Hong Kong Limited Stock Exchange
The firm plans to use the investment to scale adoption and penetration of its flagship stomach cancer blood test in Asia-Pacific markets and to develop other assays.
HighField Biopharmaceuticals to Study Immunoliposome in HER2-Low, -Positive Solid Tumors
The FDA cleared HighField's IND for a Phase I trial evaluating HF158K1, which the firm says could have advantages over HER2-targeting antibody-drug conjugates.
Gastric Cancer Risk Variants, Pathogen Interactions Found in Retrospective Study
Sequencing on gastric cancer cases and controls helped flag nine susceptibility genes, including genes that interact with Helicobacter pylori infection to bump up risk.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.